Milestone Pharmaceuticals Inc (MIST)
1.66
-0.04
(-2.35%)
USD |
NASDAQ |
Apr 24, 16:00
1.68
+0.02
(+1.20%)
After-Hours: 20:00
Milestone Pharmaceuticals Market Cap: 88.23M for April 24, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 24, 2024 | 88.23M |
| April 23, 2024 | 90.35M |
| April 22, 2024 | 86.63M |
| April 19, 2024 | 87.17M |
| April 18, 2024 | 86.63M |
| April 17, 2024 | 93.01M |
| April 16, 2024 | 93.54M |
| April 15, 2024 | 93.28M |
| April 12, 2024 | 91.95M |
| April 11, 2024 | 90.09M |
| April 10, 2024 | 88.76M |
| April 09, 2024 | 88.76M |
| April 08, 2024 | 96.73M |
| April 05, 2024 | 95.67M |
| April 04, 2024 | 93.01M |
| April 03, 2024 | 93.54M |
| April 02, 2024 | 95.67M |
| April 01, 2024 | 97.26M |
| March 28, 2024 | 95.14M |
| March 27, 2024 | 95.67M |
| March 26, 2024 | 96.20M |
| March 25, 2024 | 91.95M |
| March 22, 2024 | 92.48M |
| March 21, 2024 | 82.91M |
| March 20, 2024 | 79.72M |
| Date | Value |
|---|---|
| March 19, 2024 | 77.07M |
| March 18, 2024 | 79.19M |
| March 15, 2024 | 77.07M |
| March 14, 2024 | 75.47M |
| March 13, 2024 | 77.07M |
| March 12, 2024 | 78.93M |
| March 11, 2024 | 81.85M |
| March 08, 2024 | 80.26M |
| March 07, 2024 | 79.72M |
| March 06, 2024 | 77.07M |
| March 05, 2024 | 83.98M |
| March 04, 2024 | 82.38M |
| March 01, 2024 | 53.91M |
| February 29, 2024 | 56.25M |
| February 28, 2024 | 71.32M |
| February 27, 2024 | 73.66M |
| February 26, 2024 | 70.65M |
| February 23, 2024 | 56.92M |
| February 22, 2024 | 54.24M |
| February 21, 2024 | 52.90M |
| February 20, 2024 | 50.22M |
| February 16, 2024 | 51.23M |
| February 15, 2024 | 53.24M |
| February 14, 2024 | 50.89M |
| February 13, 2024 | 51.90M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
41.75M
Minimum
Mar 24 2020
664.92M
Maximum
Jun 28 2019
207.66M
Average
170.86M
Median
Oct 21 2020
Market Cap Benchmarks
| Acasti Pharma Inc | 27.26M |
| Aurinia Pharmaceuticals Inc | 727.43M |
| Edesa Biotech Inc | 13.67M |
| Lexaria Bioscience Corp | 28.35M |
| Xenon Pharmaceuticals Inc | 2.980B |
Market Cap Related Metrics
| PEG Ratio | -0.0369 |
| Price to Book Value | 5.261 |
| Price | 1.66 |
| Earnings Yield | -83.73% |
| PEGY Ratio | -0.0369 |